ICLR 250516 150.00C(ICLR250516C150000) Stock Price Today

US OptionsDetailed Quotes

ICLR250516C150000

Watchlist

9.10
+4.00+78.43%

15min DelayClose Apr 29 16:00 ET

9.20High8.08Low

Intraday

5D
Daily

News

Icon Q1 2025 Earnings Preview
Seeking Alpha17:35 ET
This Saia Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday
BenzingaApr 29 08:09 ET
Icon Cut to Neutral From Overweight by JP Morgan
Dow JonesApr 29 07:02 ET · Ratings
Icon Price Target Cut to $150.00/Share From $265.00 by JP Morgan
Dow JonesApr 29 07:02 ET · Ratings
J.P. Morgan Downgrades Icon PLC(ICLR.US) to Hold Rating, Cuts Target Price to $150
Moomoo NewsApr 29 05:45 ET · Ratings
ICON Earnings Preview: Recent $ICLR Insider Trading, Hedge Fund Activity, and More
Quiver QuantitativeApr 28 17:06 ET

Comments

Teddy123

Mar 20 18:39

ICON Becomes the First Large Clinical Research Organization to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management and Review

$Icon PLC (ICLR.US)$
Major Breakthrough: ICON Leads Clinical Research Evolution with AI-Powered Medidata Platform

Stock_Drift

Jan 30 21:00

$Icon PLC (ICLR.US)$

Moomoo AI

Oct 28, 2023 20:46

While ICON's earnings forecast dipped slightly, the consensus price target remains unchanged. Despite the slower expected revenue growth, ICON is still predicted to outperform the wider industry growth.

ICON Public Limited Company (NASDAQ:ICLR) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Analysts Notebook

May 24, 2022 19:18

Columns Top upgrades and downgrades on 5/24

Upgrades
• $Marqeta (MQ.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $15
• $Northwest Natural (NWN.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $53 (from $51)
• $Otis Worldwide (OTIS.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $82 (from $80)
• $Snowflake (SNOW.US)$ : Rosenblatt Upgrades to Buy from Neutral - PT $255 (from $325)
Downgrades
• $Eaton (ETN.US)$ : Barclays Downgrades to Underweight from Eq...